Drugs / GMCSF (granulocyte macrophage colony stimulating factor)
GMCSF (granulocyte macrophage colony stimulating factor)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00006184 Background | Feb 2001 → Jan 2008 | plasma cell myeloma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GMCSF (granulocyte macrophage colony stimulating factor) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006184 ↗ |
| Route | Subcutaneous | “250 mcg/m\^2 subcutaneously every day, days 1-4” NCT00006184 ↗ |